BMS - Key Persons

Adam Lenkowsky

Job Titles:

Executive Vice President, Chief Commercialization Officer

Amanda Poole - CHRO, EVP

Job Titles:

Chief Human Resources Officer
Executive Vice President

Ben Hickey

Job Titles:

President, RayzeBio, Head of Mirati

Bijal Kakrecha, a research scientist in translational medicine, relocated to Cambridge from New Jersey to work on better understanding cancer resistance. The entire Cambridge team focuses on discovering innovative targets and pathways for tumors that have not traditionally responded to Immuno-Oncology (I-O) therapies. She quickly found this central mission made her colleagues feel like a "close-knit family" in which collaboration comes naturally.

Cari Gallman

Job Titles:

Executive Vice President, Corporate Affairs

Charlie Bancroft - CFO, EVP

Job Titles:

Chief Financial Officer
Executive Vice President

Connie Walters

Job Titles:

Vice President of Strategic Sourcing
Vice President, SS & P Corporate Functions and Initiatives

Connie Walters, vice president of Strategic Sourcing and Procurement, said taking part in the GIVEs program "shaped who I am today as a person and as a leader." She was selected for the program in 2016 and now leads the overall GIVEs initiative. Connie Walters had been with BMS for a few weeks in 2013 when she heard about GIVEs during a company Town Hall meeting. She then learned employees had to be with BMS two years before they could participate. So, Walters marked her calendar and waited. And waited. And waited. Three years later in 2016, she was selected. Walters and a colleague from Israel worked with non-governmental organizations (NGOs) to teach them how to write grants and ways to tighten their controls so organizations will continue to fund their work.

David Elkins - CFO, EVP

Job Titles:

Chief Financial Officer
Executive Vice President

David Rucker

David Rucker has many roles: at Bristol Myers Squibb, he is associate director for Clinical Trial Business Capabilities, and at the Bethel Woods Center for the Arts in Bethel, New York, he is event usher, guest services representative, museum exhibit designer and even trail blazer. For seven years, David has been volunteering at the Bethel Woods Center, a nonprofit cultural organization located at the historic site of the 1969 Woodstock festival. When he discovered BMS' Volunteer Time Off program, in which eligible employees can take up to two regularly scheduled work days each year to volunteer at a charitable organization, he was eager to take part in some of the bigger projects that are done at Bethel during the work week, when there are more staff on site. I have a deep interest in the arts, and specifically that era of music and culture. The Volunteer Time Off program gave me a special opportunity to assist with a historical preservation initiative, rebuilding a trail system using old photographs, artifacts, and of course, hard work."

Deepak L. Bhatt

Job Titles:

Director of Mount Sinai Heart and the Dr. Valentin Fuster Professor of Cardiovascular Medicine at the Icahn School of Medicine

Dr. Bhatt, age 55, has served as the director of Mount Sinai Heart and the Dr. Valentin Fuster Professor of Cardiovascular Medicine at the Icahn School of Medicine since 2022. Prior to his current role, Dr. Bhatt was the executive director of interventional cardiovascular programs at Brigham and Women's Hospital and a professor of medicine at Harvard Medical School. Dr. Bhatt brings to the Board more than 20 years of research experience in acute coronary syndromes, preventive cardiology, and advanced techniques in cardiac, cerebral, and peripheral intervention. He has served as the principal or co-principal investigator for cardiovascular clinical trials focused on interventional cardiology, anti-thrombotic therapy, lipid-lowering therapy, heart failure, obesity, and diabetes, among other areas. Prior to his current position, Dr. Bhatt served as chief of cardiology at VA Boston Healthcare from 2008-2013. From 2001-2008, Dr. Bhatt held a number of roles of increasing responsibility at the Cleveland Clinic in Cleveland, Ohio. In addition to being an attending physician, he served as an associate director of the Cleveland Clinic Cardiovascular Coordinating Center, director of the interventional cardiology fellowship, as well as the associate director of the cardiovascular medicine fellowship.

Derica W. Rice

Mr. Rice, age 58, served as executive vice president (EVP) of CVS Health and president of its pharmacy benefits management (PBM) business, CVS Caremark, where he led the PBM business from March 2018 to February 2020. Prior to that, he served as the EVP of global services and CFO for Eli Lilly and Company from 2006 to 2017. During his 27-year tenure at Eli Lilly, Mr. Rice was instrumental in helping to drive the company's innovation strategy and held numerous roles in finance and operations. He is currently a member of the Boards of Directors of The Walt Disney Company, Target Corporation, and the Carlyle Group. Mr. Rice holds an MBA degree from Indiana University and a BS degree in electrical engineering from Kettering University.

Dr. Christopher Boerner - CEO, Chairman

Job Titles:

Chairman of the Board
Chief Executive Officer
Member of the Executive Committee of

Dr. Christopher Boerner, age 53, serves as board chair for Bristol Myers Squibb since April 2024 and chief executive officer since November 2023. Prior to assuming that role, he was executive vice president, chief operating officer and chief executive officer designate since April 2023. Previously, he served as executive vice president, chief commercialization officer from August 2018 to April 2023. Dr. Boerner served as head of International Markets at Bristol Myers Squibb from September 2017 to July 2018, and as president and head of U.S. Commercial Markets from February 2015 to September 2017. From 2010 to 2015, Dr. Boerner held leadership roles of increasing responsibility at Seattle Genetics, Inc. From 2002 to 2010, he served in marketing leadership roles at Genentech, a member of the Roche Group, focused on strategy, development and commercialization across multiple oncology products and immunology. Earlier in his career, he worked for McKinsey & Company, serving global pharmaceutical and biotechnology clients. Dr. Boerner is a member of the Executive Committee of BIO (Biotechnology Innovation Organization) and a member of the National Council for Arts and Sciences at Washington University.

Gerald L. Storch

Job Titles:

Chief Executive Officer, Storch Advisors. Former Chief Executive Officer, Hudson 's Bay Company

Mr. Storch, age 66, has served as chief executive officer of Storch Advisors, a global business and advisory firm, since November 2017. From November 2013 to January 2015, he served as chairman and chief executive officer. He served as chief executive officer of Hudson's Bay Company from January 2015 to November 2017. He also served as chairman of Toys"R"Us, Inc. from February 2006 to November 2013 and chief executive officer of Toys"R"Us from February 2006 to May 2013. Prior to joining Toys"R"Us, Mr. Storch served as vice chairman of Target Corporation. He joined Target in 1993 as senior vice president of strategy and served in roles of increasing seniority over the next 12 years. Prior to joining Target, Mr. Storch was a partner at McKinsey & Company. He is a director of Fanatics, Inc.

Greg Meyers

Job Titles:

Executive Vice President, Chief Digital & Technology Officer

James Byrnes

Job Titles:

Senior Manager in Facilities

Jana Low

Job Titles:

from Founding Member and Rider to Patient and Survivor
Regional Business Director, Hematology, Central East U.S

Jana Low rode C2C4C with several names written on her jersey. They included coworkers and family members who faced cancer. She rode for them and for herself, because Low's a cancer survivor, too. Low, who is regional business director, Hematology, Central East U.S., was one of the Oncology employees who helped create C2C4C nine years earlier. She served as operations manager for the inaugural event and helped convince 55 riders to pedal coast to coast from Connecticut to California in May of that year. The employee-led event has gained the attention and appreciation of countless cancer patients who riders meet along the route. Low recalls meeting a man who lost a leg to sarcoma, and he asked if he could talk with BMS employees before they left their hotel one morning. The inspirational story he shared about his cancer journey stayed with riders for the rest of the route and beyond. Low knows the work that goes into preparing for C2C4C. In 2017, she was selected to ride. She trained hard but was unable to finish. Five years later, after a cancer diagnosis and successful treatment, Low was back. She helped lead the team in the final stages through Pennsylvania and New Jersey to the finish line.

Julia A. Haller

Job Titles:

Director at Ophtea Limited
Ophthalmologist - in - Chief, Wills Eye Hospital

Dr. Haller, age 68, has served since 2007 as ophthalmologist-in-chief of Wills Eye Hospital in Philadelphia, PA, where she holds the William Tasman, MD endowed chair. She is professor and chair of the department of ophthalmology at Sidney Kimmel Medical College at Thomas Jefferson University and Thomas Jefferson University Hospitals. A magna cum laude graduate of Princeton, Dr. Haller received her MD degree from Harvard Medical School. She trained at the Wilmer Eye Institute at Johns Hopkins where she served as the first female chief resident. She then joined the Johns Hopkins faculty, where she held the Katharine Graham Chair in Ophthalmology before her move to lead Wills. One of the world's most renowned retina surgeons, Dr. Haller has innovated translational advances against blindness on many fronts, including sustained drug delivery devices, ocular pharmacotherapy, retinal "chip" implants, gene therapy, telemedicine and combating health care disparities. Elected to the National Academy of Medicine, she has held many leadership roles in medicine. She serves as Chair of the Board of Trustees for the College of Physicians of Philadelphia, Chair of the Heed Ophthalmic Foundation Board and President of the John Hopkins Medicine Alumni Society. Dr. Haller also served as a member of the Board of Trustees of Princeton University, and a consultant at Children's Hospital of Philadelphia. Dr. Haller currently serves as a director at Ophtea Limited and Outlook Therapeutics, Inc., and is a former director of Eyenovia, Inc.

Karen H. Vousden

Job Titles:

Principal Group Leader of the Francis Crick Institute and Former Chief Scientist of Cancer Research UK

Karin Shanahan

Job Titles:

Executive Vice President, Global Product Development & Supply

Kim Jablonski

Job Titles:

Chief Compliance & Ethics Officer

Lynelle B. Hoch

Job Titles:

President, Cell Therapy Organization

Manuel Hidalgo Medina

Job Titles:

Chief, Division of Hematology and Medical Oncology, Weill Cornell Medical College and Attending Physician, New York - Presbyterian Hospital

Matt Labrecque

Job Titles:

Employee
Scientist, Drug Discovery Research

Matt is a Bristol Myers Squibb employee who lives with multiple sclerosis and clinical depression, and he has personally experienced the impact that scientific advances can have on an individual patient's life. "I am someone with cognitive and physical disabilities, as well as chronic illness," she said. "Without receiving treatment for my conditions, I wouldn't be able to do the amazing work I do today to prepare protocol documents that lead, in the long run, to helping patients get the medicines they need. I know firsthand that medicine can change lives." Her successful work in R&D is supported by BMS' culture, which emphasizes diversity and inclusion. Julie is an active project lead in the Disability Advancement Workplace Network (DAWN), one of the company's People and Business Resource Group s (PBRG), and as part of her work supporting the Colleague pillar finds ways to increase recruitment of people with disabilities to BMS. Recently, her team took part in a training session on neurodiversity led by a facilitator from DAWN, and colleagues had positive feedback about the session, expressing interest in becoming allies and learning more about neurodiversity and cognitive aspects of diversity. "BMS encourages employees to bring their authentic selves to work," said Julie. "I believe people are happier, and are ultimately better at their jobs, when they can get the right support and work with colleagues who want them to reach their full potential." Like Julie, Matt has had the opportunity to support his colleagues through sharing his personal perspective. Matt is an active DAWN member, and his work has led to involvement in discussions of accessibility around new initiatives, ensuring that barriers are removed and inclusion of colleagues with disabilities is top of mind. He is also the co-lead of the Massachusetts Mental Health Ally (MHA) program, which launched in collaboration with DAWN late last year. In that role, he helps to develop programs to reduce stigma around mental health.

Monique Phillips

Job Titles:

Global Lead of the Black Organization for Leadership & Development ( BOLD )
Lead of the Black Organization for Leadership & Development ( BOLD ), Tells Us about BOLD 's Mission and Her Goals for the Group Moving Forward

Monique Phillips, global lead of the Black Organization for Leadership & Development (BOLD), tells us about BOLD's mission and her goals for the group moving forward. Monique Phillips: At Bristol Myers Squibb, our Employee Resource Groups have evolved into People and Business Resource Groups (PBRGs), which means that in addition to the sense of belonging and professional development that Employee Resource Groups offer, these employee groups are designed to drive innovation and impact business results.